Ba 679 BR Inhalation Powder
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ba 679 BR Inhalation Powder, covering 2014-06-24 to 2014-06-24. Get the full timeline:
Most recent: Clinical Trial Update: Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]